Tags

Type your tag names separated by a space and hit enter

Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.
Disabil Rehabil 2018; 40(17):1989-1996DR

Abstract

AIM

To assess the prevalence, severity and impact of fatigue on individuals with joint hypermobility syndrome (JHS)/Ehlers-Danlos syndrome - hypermobility type (EDS-HT) and establish potential determinants of fatigue severity in this population.

METHODS

Questionnaires on symptoms and signs related to fatigue, quality of life, mental health, physical activity participation and sleep quality were completed by people with JHS/EDS-HT recruited through two social media sites. Multiple regression analysis was performed to identify predictors of fatigue in this population.

RESULTS

Significant fatigue was reported by 79.5% of the 117 participants. Multiple regression analysis identified five predictors of fatigue severity, four being potentially modifiable, accounting for 52.3% of the variance in reported fatigue scores. Predictors of fatigue severity were: the self-perceived extent of joint hypermobility, orthostatic dizziness related to heat and exercise, levels of participation in personal relationships and community, current levels of physical activity and dissatisfaction with the diagnostic process and management options provided for their condition.

CONCLUSION

Fatigue is a significant symptom associated with JHS/EDS-HT. Assessment of individuals with this condition should include measures of fatigue severity to enable targeted management of potentially modifiable factors associated with fatigue severity. Implications for rehabilitation Fatigue is a significant symptom reported by individuals affected by joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. Potentially modifiable features that contribute to fatigue severity in this population have been identified. Targeted management of these features may decrease the severity and impact of fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.

Authors+Show Affiliations

a Discipline of Biomedical Science, School of Medical Sciences , Sydney Medical School, The University of Sydney , Sydney , Australia.b Discipline of Physiotherapy, Faculty of Health Sciences , The University of Sydney , Sydney , Australia.a Discipline of Biomedical Science, School of Medical Sciences , Sydney Medical School, The University of Sydney , Sydney , Australia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28482708

Citation

Krahe, Anne Maree, et al. "Features That Exacerbate Fatigue Severity in Joint Hypermobility syndrome/Ehlers-Danlos Syndrome - Hypermobility Type." Disability and Rehabilitation, vol. 40, no. 17, 2018, pp. 1989-1996.
Krahe AM, Adams RD, Nicholson LL. Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. Disabil Rehabil. 2018;40(17):1989-1996.
Krahe, A. M., Adams, R. D., & Nicholson, L. L. (2018). Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. Disability and Rehabilitation, 40(17), pp. 1989-1996. doi:10.1080/09638288.2017.1323022.
Krahe AM, Adams RD, Nicholson LL. Features That Exacerbate Fatigue Severity in Joint Hypermobility syndrome/Ehlers-Danlos Syndrome - Hypermobility Type. Disabil Rehabil. 2018;40(17):1989-1996. PubMed PMID: 28482708.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. AU - Krahe,Anne Maree, AU - Adams,Roger David, AU - Nicholson,Leslie Lorenda, Y1 - 2017/05/09/ PY - 2017/5/10/pubmed PY - 2018/10/23/medline PY - 2017/5/10/entrez KW - Health-related quality of life KW - hypermobile Ehlers–Danlos syndrome KW - hypermobility syndrome KW - mental health KW - orthostatic intolerance KW - physical activity SP - 1989 EP - 1996 JF - Disability and rehabilitation JO - Disabil Rehabil VL - 40 IS - 17 N2 - AIM: To assess the prevalence, severity and impact of fatigue on individuals with joint hypermobility syndrome (JHS)/Ehlers-Danlos syndrome - hypermobility type (EDS-HT) and establish potential determinants of fatigue severity in this population. METHODS: Questionnaires on symptoms and signs related to fatigue, quality of life, mental health, physical activity participation and sleep quality were completed by people with JHS/EDS-HT recruited through two social media sites. Multiple regression analysis was performed to identify predictors of fatigue in this population. RESULTS: Significant fatigue was reported by 79.5% of the 117 participants. Multiple regression analysis identified five predictors of fatigue severity, four being potentially modifiable, accounting for 52.3% of the variance in reported fatigue scores. Predictors of fatigue severity were: the self-perceived extent of joint hypermobility, orthostatic dizziness related to heat and exercise, levels of participation in personal relationships and community, current levels of physical activity and dissatisfaction with the diagnostic process and management options provided for their condition. CONCLUSION: Fatigue is a significant symptom associated with JHS/EDS-HT. Assessment of individuals with this condition should include measures of fatigue severity to enable targeted management of potentially modifiable factors associated with fatigue severity. Implications for rehabilitation Fatigue is a significant symptom reported by individuals affected by joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. Potentially modifiable features that contribute to fatigue severity in this population have been identified. Targeted management of these features may decrease the severity and impact of fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type. SN - 1464-5165 UR - https://www.unboundmedicine.com/medline/citation/28482708/Features_that_exacerbate_fatigue_severity_in_joint_hypermobility_syndrome/Ehlers_Danlos_syndrome___hypermobility_type_ L2 - http://www.tandfonline.com/doi/abs/10.1080/09638288.2017.1323022 DB - PRIME DP - Unbound Medicine ER -